Catalyst
Slingshot members are tracking this event:
Phase 3 SUNFISH trial data of PTC Therapeutics'(PTC) Risdiplam in Spinal Muscular Atrophy to be presented at the International Scientific Congress on SMA
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 06, 2020
Occurred Source:
https://smanewstoday.com/2020/02/06/risdiplam-leads-to-motor-skills-gains-or-stability-in-sma-type-2-and-3-sunfish-trial-reports/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sunfish, Risdiplam, Spinal Muscular Atrophy
